Showing results (121-130 of 236) with videos related to

Sort By:
Pageof 24
AIDS (London, England)|January 12, 2016
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive personsLene Ryom, Jens Dilling Lundgren, Stéphane De Wit, et al.
The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.
Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.
Blood|March 4, 2011
HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytesJulia Bohlius, Kurt Schmidlin, François Boué, et al.
The Journal of Infectious Diseases|May 18, 2020
Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver StudyDitte Marie Kirkegaard-Klitbo, Andreas Fuchs, Stefan Stender, et al.
AIDS (London, England)|July 28, 2023
Long-term outcomes after tuberculosis for people with HIV in eastern EuropeChristian Kraef, Adrian Bentzon, Ashley Roen, et al.
Journal of the National Cancer Institute|December 22, 2017
Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin LymphomaLeah Shepherd, Lene Ryom, Matthew Law, et al.
BMC Infectious Diseases|October 7, 2021
Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort studyChristian Kraef, Adrian Bentzon, Alexander Panteleev, et al.
Open Forum Infectious Diseases|November 2, 2022
Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional StudyCas Isfordink, Anders Boyd, Amanda Mocroft, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?, Amanda Mocroft, Peter Reiss, et al.
Pageof 24